Zelda Therapeutics Ltd. Stock Price - ZLDAF

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Zelda Therapeutics Ltd. (QB) ZLDAF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.001 +2.5% 0.041 0.042 0.04 0.042 0.04 15:19:50
Bid Price Ask Price Spread Spread % News
0.04 0.042 0.002 4.76% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
12 80,029 $ 0.0406 $ 3.25k 79.13k 0.0000 - 0.04
Last Trade Time Type Quantity Stock Price Currency
15:19:50 5,000 $0.04 USD

Zelda Therapeutics Ltd. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 30.97M 755.34M $ -1.73M - -17.90 755.34M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Zelda Therapeutics Ltd. (QB) News

Latest ZLDAF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZLDAF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week00.04200.0000080k0--
1 Month00.04200.0000080k0--
3 Months00.04200.0000080k0--
6 Months00.04200.0000080k0--
1 Year00.04200.0000080k0--
3 Years00.04200.0000080k0--
5 Years00.04200.0000080k0--

Zelda Therapeutics Ltd. (QB) Description

Zelda Therapeutics ("Zelda") is an Australian-based bio-pharmaceutical company that is focused on developing a range of cannabinoid-based formulations for the treatment of a variety of medical conditions. The Company has a two-pronged strategy comprising: A human clinical trial programme focused on insomnia, autism and eczema with activities in Australia and Chile. A pre-clinical research programme examining the effect of cannabinoids in breast, brain and pancreatic cancer. It has partnered with the world's leading cancer cannabis researchers at Complutense University Madrid in Spain to conduct certain pre-clinical work testing cannabis-based formulations known to have an effect in humans in order to generate data packs in a form expected by regulators and the pharmaceutical industry. A similar programme is in place with the Australian Telethon Kids Institute targeting paediatric brain cancer and Curtin University targeting pancreatic cancer.


Your Recent History
USOTC
ZLDAF
Zelda Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.